U-2902

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameU-2902
Drug Alias NameConopeptide (Kineta)neuronal nicotinic acetylcholine ion channels blocker (Kineta)neuronal nicotinic acetylcholine ion channels blocker (KPI Therapeutics)CSP Conopeptide (Kineta/KPI Therapeutics)U-2902
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuronal acetylcholine receptor subunit alpha-10 blockersNeuronal acetylcholine receptor subunit alpha-9 blockers
TargetsNeuronal acetylcholine receptor subunit alpha-10Neuronal acetylcholine receptor subunit alpha-9
Therapy Area/IndicationsWounds and InjuriesNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Utah
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKv1.3 Therapeutics IncKineta IncThe University Of Utah
Active IndicationsN/A
Inactive IndicationsWounds and InjuriesNeuralgia

Other Information

ATC CodeN/A
Related LinksN/A